- Home
- ORMP vs RVPH Comparison
ORMP vs RVPH Comparison
Compare ORMP & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORMP
- RVPH
- Stock Information
- Founded
- ORMP 2002
- RVPH 2006
- Country
- ORMP United States
- RVPH United States
- Employees
- ORMP N/A
- RVPH N/A
- Industry
- ORMP Biotechnology: Pharmaceutical Preparations
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- ORMP Health Care
- RVPH Health Care
- Exchange
- ORMP Nasdaq
- RVPH Nasdaq
- Market Cap
- ORMP N/A
- RVPH 32.8M
- IPO Year
- ORMP N/A
- RVPH N/A
- Fundamental
- Price
- ORMP $2.17
- RVPH $0.40
- Analyst Decision
- ORMP Hold
- RVPH Strong Buy
- Analyst Count
- ORMP 1
- RVPH 5
- Target Price
- ORMP N/A
- RVPH $9.00
- AVG Volume (30 Days)
- ORMP 61.6K
- RVPH 2.8M
- Earning Date
- ORMP 08-15-2025
- RVPH 08-13-2025
- Dividend Yield
- ORMP N/A
- RVPH N/A
- EPS Growth
- ORMP N/A
- RVPH N/A
- EPS
- ORMP N/A
- RVPH N/A
- Revenue
- ORMP $2,000,000.00
- RVPH N/A
- Revenue This Year
- ORMP N/A
- RVPH N/A
- Revenue Next Year
- ORMP N/A
- RVPH N/A
- P/E Ratio
- ORMP N/A
- RVPH N/A
- Revenue Growth
- ORMP 196.74
- RVPH N/A
- 52 Week Low
- ORMP $1.82
- RVPH $0.30
- 52 Week High
- ORMP $3.09
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- ORMP 49.24
- RVPH 33.75
- Support Level
- ORMP $2.09
- RVPH $0.35
- Resistance Level
- ORMP $2.22
- RVPH $0.83
- Average True Range (ATR)
- ORMP 0.09
- RVPH 0.06
- MACD
- ORMP -0.00
- RVPH -0.02
- Stochastic Oscillator
- ORMP 55.26
- RVPH 17.98
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.